FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 346:222-224 January 24, 2002 Number 4 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Walsh, T. J. PubMed Citation

Organ transplantation and major cancer chemotherapy are often associated with prolonged neutropenia (defined as less than 500 polymorphonuclear neutrophils per cubic millimeter), alterations in phagocyte function and lymphopenia due to immunosuppressive agents, and disruption of mucosal defense barriers resulting from mucositis and the presence of indwelling catheters. All these changes can lead to colonization and to invasion by microorganisms — as signaled by fever. More than 30 years ago, the empirical use of broad-spectrum antimicrobial drugs was shown to reduce the frequency of bacteremia and sepsis among such patients. In the 1980s, it was learned that persistent or relapsing fever . . . [Full Text of this Article]

The Choice of Therapy

Response to Therapy

Use of Prophylactic Antifungal Agents

This article has been cited by other articles:

• Tavares, E., Minano, F. J., Maldonado, R., Dascombe, M. J. (2006). Endotoxin fever in granulocytopenic rats: evidence that brain cyclooxygenase-2 is more important than circulating prostaglandin E2. J. Leukoc. Biol. 80: 1375-1387 [Abstract] [Full Text]  
• Tavares, E., Maldonado, R., Ojeda, M. L., Minano, F. J. (2005). Circulating Inflammatory Mediators during Start of Fever in Differential Diagnosis of Gram-Negative and Gram-Positive Infections in Leukopenic Rats. CVI 12: 1085-1093 [Abstract] [Full Text]  
• Nichols, W. G. (2003). Management of Infectious Complications in the Hematopoietic Stem Cell Transplant Recipient. J Intensive Care Med 18: 295-312 [Abstract]  
• Mutnick, A. H, Kirby, J. T, Jones, R. N (2003). CANCER Resistance Surveillance Program: Initial Results from Hematology-Oncology Centers in North America. The Annals of Pharmacotherapy 37: 47-56 [Abstract] [Full Text]